IRIS Accounts Production v26.3.0.614 08376373 director 1.2.25 31.1.26 31.1.26 true false true false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh083763732025-01-31083763732026-01-31083763732025-02-012026-01-31083763732024-01-31083763732024-02-012025-01-31083763732025-01-3108376373ns15:EnglandWales2025-02-012026-01-3108376373ns14:PoundSterling2025-02-012026-01-3108376373ns10:Director12025-02-012026-01-3108376373ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3108376373ns10:SmallEntities2025-02-012026-01-3108376373ns10:AuditExempt-NoAccountantsReport2025-02-012026-01-3108376373ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3108376373ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3108376373ns10:FullAccounts2025-02-012026-01-3108376373ns10:OrdinaryShareClass12025-02-012026-01-3108376373ns10:RegisteredOffice2025-02-012026-01-3108376373ns5:CurrentFinancialInstruments2026-01-3108376373ns5:CurrentFinancialInstruments2025-01-3108376373ns5:Non-currentFinancialInstruments2026-01-3108376373ns5:Non-currentFinancialInstruments2025-01-3108376373ns5:ShareCapital2026-01-3108376373ns5:ShareCapital2025-01-3108376373ns5:RevaluationReserve2026-01-3108376373ns5:RevaluationReserve2025-01-3108376373ns5:RetainedEarningsAccumulatedLosses2026-01-3108376373ns5:RetainedEarningsAccumulatedLosses2025-01-3108376373ns5:FurnitureFittings2025-02-012026-01-3108376373ns5:ComputerEquipment2025-02-012026-01-3108376373ns5:LandBuildings2025-01-3108376373ns5:FurnitureFittings2025-01-3108376373ns5:ComputerEquipment2025-01-3108376373ns5:LandBuildings2025-02-012026-01-3108376373ns5:LandBuildings2026-01-3108376373ns5:FurnitureFittings2026-01-3108376373ns5:ComputerEquipment2026-01-3108376373ns5:LandBuildings2025-01-3108376373ns5:FurnitureFittings2025-01-3108376373ns5:ComputerEquipment2025-01-3108376373ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3108376373ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3108376373ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2026-01-3108376373ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-01-3108376373ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2026-01-3108376373ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-01-3108376373ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2026-01-3108376373ns5:MoreThanFiveYearsns5:Non-currentFinancialInstruments2025-01-3108376373ns5:Secured2026-01-3108376373ns5:Secured2025-01-3108376373ns10:OrdinaryShareClass12026-01-3108376373ns5:RetainedEarningsAccumulatedLosses2025-01-3108376373ns5:RevaluationReserve2025-01-3108376373ns5:RetainedEarningsAccumulatedLosses2025-02-012026-01-31
REGISTERED NUMBER: 08376373 (England and Wales)







Unaudited Financial Statements

for the Year Ended 31st January 2026

for

Arnolds Pharmacy Limited

Arnolds Pharmacy Limited (Registered number: 08376373)






Contents of the Financial Statements
for the Year Ended 31st January 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Arnolds Pharmacy Limited

Company Information
for the Year Ended 31st January 2026







DIRECTOR: Mr O N Hamid





REGISTERED OFFICE: 21 Nelson Road
Westward Ho
Bideford
Devon
EX39 1LF





REGISTERED NUMBER: 08376373 (England and Wales)





ACCOUNTANTS: Dunkley's
Woodlands Grange
Woodlands Lane
Bradley Stoke
Bristol
United Kingdom
BS32 4JY

Arnolds Pharmacy Limited (Registered number: 08376373)

Balance Sheet
31st January 2026

31.1.26 31.1.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 438,049 435,541
Investment property 5 475,000 475,000
913,049 910,541

CURRENT ASSETS
Stocks 35,000 37,000
Debtors 6 263,912 318,550
Cash at bank 285,737 605,960
584,649 961,510
CREDITORS
Amounts falling due within one year 7 264,553 548,816
NET CURRENT ASSETS 320,096 412,694
TOTAL ASSETS LESS CURRENT LIABILITIES 1,233,145 1,323,235

CREDITORS
Amounts falling due after more than one year 8 - (67,825 )

PROVISIONS FOR LIABILITIES (34,231 ) (41,760 )
NET ASSETS 1,198,914 1,213,650

CAPITAL AND RESERVES
Called up share capital 10 100 100
Revaluation reserve 11 147,886 147,886
Retained earnings 11 1,050,928 1,065,664
SHAREHOLDERS' FUNDS 1,198,914 1,213,650

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Arnolds Pharmacy Limited (Registered number: 08376373)

Balance Sheet - continued
31st January 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 20th October 2026 and were signed by:





Mr O N Hamid - Director


Arnolds Pharmacy Limited (Registered number: 08376373)

Notes to the Financial Statements
for the Year Ended 31st January 2026

1. STATUTORY INFORMATION

Arnolds Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The financial statements are presented in pounds sterling (£), which is the company’s functional and presentation currency. Amounts are rounded to the nearest pound.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

All revenue arises in the UK from a single activity.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Computer equipment - 33.33% on cost

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Arnolds Pharmacy Limited (Registered number: 08376373)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2026

2. ACCOUNTING POLICIES - continued

Freehold property
Freehold property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in the profit or loss.

Cash & cash equivalents
Cash comprises cash on hand and demand deposits.
Cash equivalents comprise short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value.

Going concern
The financial statements have been prepared on a going concern basis. The directors have considered the company’s financial position and are satisfied that it has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the going concern basis has been adopted in preparing the financial statements.

Judgements and Estimates
Property valuation is based on directors' estimates using market assumptions and is subject to uncertainty.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2025 - 14 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold and Computer
property fittings equipment Totals
£    £    £    £   
COST OR VALUATION
At 1st February 2025 425,000 23,659 10,214 458,873
Additions - - 5,180 5,180
Disposals - (250 ) (3,949 ) (4,199 )
At 31st January 2026 425,000 23,409 11,445 459,854
DEPRECIATION
At 1st February 2025 - 13,953 9,379 23,332
Charge for year - 1,456 1,123 2,579
Eliminated on disposal - (157 ) (3,949 ) (4,106 )
At 31st January 2026 - 15,252 6,553 21,805
NET BOOK VALUE
At 31st January 2026 425,000 8,157 4,892 438,049
At 31st January 2025 425,000 9,706 835 435,541

Arnolds Pharmacy Limited (Registered number: 08376373)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2026

4. TANGIBLE FIXED ASSETS - continued

Cost or valuation at 31st January 2026 is represented by:

Fixtures
Freehold and Computer
property fittings equipment Totals
£    £    £    £   
Valuation in 2020 50,000 - - 50,000
Valuation in 2022 50,000 - - 50,000
Valuation in 2023 50,000 - - 50,000
Valuation in 2024 25,000 - - 25,000
Cost 250,000 23,409 11,445 284,854
425,000 23,409 11,445 459,854

If freehold property had not been revalued it would have been included at the following historical cost:

31.1.26 31.1.25
£    £   
Cost 250,000 250,000

Freehold property was valued on an open market basis on 31st January 2026 by the director .

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1st February 2025
and 31st January 2026 475,000
NET BOOK VALUE
At 31st January 2026 475,000
At 31st January 2025 475,000

Fair value at 31st January 2026 is represented by:
£   
Valuation in 2024 10,000
Cost 465,000
475,000

If investment property had not been revalued it would have been included at the following historical cost:

31.1.26 31.1.25
£    £   
Cost 465,000 465,000

Investment property was valued on an open market basis on 31st January 2026 by the director .

Arnolds Pharmacy Limited (Registered number: 08376373)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2026

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.1.25
£    £   
Other debtors 7,906 -
VAT 57,426 62,406
Prepayments and accrued income 195,870 254,147
Prepayments 2,710 1,997
263,912 318,550

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.26 31.1.25
£    £   
Bank loans and overdrafts - 16,774
Other loans - 100,000
Trade creditors 253,398 256,478
Tax - 41,456
Social security and other taxes 7,987 5,386
Other creditors 1,416 1,145
Directors' current accounts 419 126,255
Accrued expenses 1,333 1,322
264,553 548,816

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.1.26 31.1.25
£    £   
Bank loans - 1-2 years - 10,107
Bank loans - 2-5 years - 20,322
Bank loans more 5 yr by instal - 37,396
- 67,825

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 37,396

9. SECURED DEBTS

The following secured debts are included within creditors:

31.1.26 31.1.25
£    £   
Bank loans - 84,599

Debentures existed, including a fixed and floating charge over all present freehold property and a fixed and floating charge over all remaining assets, both present and future. These charges were fully satisfied in May 2025.

Arnolds Pharmacy Limited (Registered number: 08376373)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2026

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.26 31.1.25
value: £    £   
100 Ordinary £1 100 100

11. RESERVES
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1st February 2025 1,065,664 147,886 1,213,550
Deficit for the year (14,236 ) (14,236 )
Dividends (500 ) (500 )
At 31st January 2026 1,050,928 147,886 1,198,814